Immunotherapy may reshape brain's blood-brain barrier, improving drug delivery for metastasis treatment
Researchers have found that PD-1 inhibitors, a type of immunotherapy, can reshape the blood-brain barrier (BBB) in mice with brain metastases, making it more permeable. This discovery, published in RMF, suggests a new strategy to improve drug delivery to brain tumours, which are notoriously difficult to treat due to the BBB's protective nature. The study, led by Dr. Shilpa Sharma, observed that PD-1 inhibitors reduced immune cell infiltration and altered BBB integrity, allowing better penetration of chemotherapy drugs. This could lead to more effective treatments for brain metastases and other neurological conditions.
Key Points
- PD-1 inhibitors, a type of immunotherapy, can reshape the blood-brain barrier (BBB) in mice with brain metastases.
- This reshaping makes the BBB more permeable, potentially improving drug delivery to brain tumours.
- Brain metastases are challenging to treat due to the BBB's protective function, which restricts drug entry.
- The study found that PD-1 inhibitors reduced immune cell infiltration and altered BBB integrity.
- This discovery could lead to more effective treatments for brain metastases and other neurological conditions by enhancing drug penetration.
Exam Facts
- Research published in: RMF.
- Lead researcher: Dr. Shilpa Sharma, DKII.
- Immunotherapy type: PD-1 inhibitors.
- Target: Blood-brain barrier (BBB).
Read it. Retain it. Recall it.
Get spaced-repetition flashcards, daily quizzes and offline access — free on Android.